Key Metrics of Zydus Wellness
About Zydus Wellness
Sectors
Company details
- Website
- zyduswellness.com
- Registered office
- Zydus Corporate Park,scheme No. 63, Survey No. 536 Khoraj(gandhinagar),nr. Vaishnodevi Circle, Ahmed, Ahmedabad, In-gj, 382481
- Listed
- NSE: ZYDUSWELL Β· βΉ463.35
Operational Areas of Zydus Wellness
Company summary
Entity details
Compliance
Industry classification
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit ratings
Rating history
Rating actions
| Date | Agency | Action | Long term | Short term | Outlook | Rated amount | Rationale |
|---|---|---|---|---|---|---|---|
| 29 Oct 2020 | CARE | Other | β | β | β | β | View |
| 02 Jan 2020 | CARE | Reaffirmed | AA+ | β | Stable | βΉ1,500 Cr | View |
| 31 Dec 2018 | CARE | Other | β | β | β | β | View |
Credit strengths (CARE, Jan 2020)
+ Low leverage: ZWLβs leverage remains low marked by an overall gearing ratio of 0.46 times as on March 31, 2019. During
FY19, ZWL acquired HIPL for a consideration of around Rs.4,600 crore. ZWL issued NCDs of Rs.1,500 crore to part-fund the acquisition. However, promoters along with institutional investors infused equity share capital of around Rs.2,575 crore which led to strengthening of the tangible net-worth base to Rs.3,365 crore as on March 31, 2019 (including acquired goodwill of Rs.3,797 crore as on March 31, 2019). Leverage of ZWL is expected to remain healthy as the company does
Credit challenges
β
Could lead to an upgrade
ο§ Significant increase in market share of its key products resulting in significant improvement in its profitability and debt coverage indicators ο§ Improvement in Return on Capital Employed (ROCE) to more than 12% on sustained basis
Could lead to a downgrade
ο§ PBILDT margin remaining less than 15% from FY21 onwards on a sustained basis. ο§ Any large size debt-funded capex or acquisition adversely impacting credit metrics of ZWL or its parent, CHL or lower than envisaged support from its parent
Borrowings & rated debt
Facility mix
Rated facilities
| Facility | Type | Previous | Current | Change | Rating | Action | Agency |
|---|---|---|---|---|---|---|---|
| Non-convertible (Rupees One Thousand Five debenture issue Hundred Crore only) | Debentures & bonds | β | βΉ1,500 Cr | β | AA+ (Stable) | Reaffirmed | CARE |
Debt instruments
| ISIN | Instrument | Type | Coupon | Issued | Maturity | Amount | Rating | Status |
|---|---|---|---|---|---|---|---|---|
| INE768C07017 | β | Debentures & bonds | β | β | β | β | β | Not stated |
| INE768C07033 | β | Debentures & bonds | β | β | β | β | β | Not stated |
| INE768C07025 | β | Debentures & bonds | β | β | β | β | β | Withdrawn |
CARE ratings on record (checked 24 Oct 2026)
| Instrument | Amount | Rating |
|---|---|---|
| Non Convertible Debentures | β | Withdrawn |
Credit assessment Β· Manufacturing
Rating Methodology β Manufacturing Companies (Mar 2025) Β· Standalone accounts Β· FY 2025-26
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Cooperating |
| Credit enhancement | None β standalone rating |
| Next action stable or better (model) | 35% |
| Information on file | 67% Β· missing: Capex / investment plans, Auditor details, Recent rating review (last 15 months) |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Borrowing & funding lifecycle
- Credit outlook model: 41% chance the next rating action is stable or better
What happened, step by step
- Jan 2020 β Full repayment of NCDs
- Oct 2020 β βΉ1,500 cr raised through NCDs / bonds from ZWL
βThe acquisition was funded through NCDs of Rs.1,500 crore raised by ZWL and rest through a mix of equity infusion (including from CHL and Zydus Family Trust) and internal accruals.β
- Jan 2020 β βΉ1,475 cr raised through equity
- Jan 2020 β Full repayment of NCDs
βDuring FY19, CHL along with promoter family infused equity share capital of Rs.1,475 crore to fund the acquisition of HIPL.β
- Jan 2020 β βΉ1,500 cr raised through NCDs / bonds
- Jan 2020 β Full repayment of NCDs
βZWL issued NCDs of Rs.1,500 crore to part-fund the acquisition.β
Rated limits by facility
Timeline
From the report
The acquisition was funded through NCDs of Rs.1,500 crore raised by ZWL and rest through a mix of equity infusion (including from CHL and Zydus Family Trust) and internal accruals.
From the report
During FY19, CHL along with promoter family infused equity share capital of Rs.1,475 crore to fund the acquisition of HIPL.
From the report
ZWL issued NCDs of Rs.1,500 crore to part-fund the acquisition.
From the report
However, promoters along with institutional investors infused equity share capital of around Rs.2,575 crore which led to strengthening of the tangible net-worth base to Rs.3,365 crore as on March 31, 2019 (including acquired goodwill of Rs.3,797 crore as on March 31, 2019).
From the report
Further, the repayment of NCDs issued by ZWL starts from January 14, 2022 thereby giving it time to build-up sufficient cash accruals to service the debt.
From the report
Comfortable funding pattern of proposed acquisition: Historically, ZWL has remained a term debt free company with healthy cash and liquid investment as on March 31, 2018.
From the report
Out of equity portion of Rs.3,100 crore, promoter family, CHL and two private equity firms are expected to infuse fresh equity of Rs.2,575 crore while the rest is proposed to be funded through existing cash/bank balance of ZWL.
From the report
ZWL has proposed to issue Non- Convertible Debentures (NCD) of Rs.1,500 crore for the proposed acquisition.
From the report
The company holds cash and liquid investment of around Rs.560 crore as on September 30, 2018 out of which Rs.525 crore is expected to be utilized for proposed acquisition.
From the report
Further, as per the term sheet of the proposed NCD issue, repayment of NCD should start from March 2022, providing sufficient cushion during the business integration period.
Lender names, bank charges and audited borrowings are part of Premium.
Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.
Registered office and contact
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Zydus Wellness
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
 Patanjali Foods |
Dal & Pulses Β· Food & Beverages | patanjalifoods.com | β | Mumbai, India |
 Swiggy |
E-commerce Β· Food Delivery | swiggy.com | 2014 | Bangalore, India |
 Tata Consumer Products |
Dal & Pulses Β· Food & Beverages | tataconsumer.com | 1962 | Kolkata, India |
| Biscuits & Bakery Β· Food & Beverages | britannia.co.in | 1892 | Kolkata, India | |
 Heritage Foods |
Dairy, Ghee & Milk Products Β· Food & Beverages | heritagefoods.in | 1992 | Hyderabad, India |
| HINDUSTAN FOODS LIMITED | Β· Manufacturing (Food stuffs) | β | β | Mumbai, Maharashtra, India |
| DHAMPUR BIO ORGANICS LIMITED | Β· Manufacturing (Food stuffs) | β | β | Moradabad, Uttar Pradesh, India |
| Packaged Foods & Confectionery Β· Food & Beverages | sapphirefoods.in | β | Panchkula, Haryana, India | |
| PRIVI SPECIALITY CHEMICALS LIMITED | Packaged Foods & Confectionery Β· Food & Beverages | β | β | Navi Mumbai, Maharashtra, India |
| Packaged Foods & Confectionery Β· Food & Beverages | mcleodrussel.com | 1869 | Kolkata, India |
Similar companies
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Health foods and personal care
Filings
No filings on record yet.